Literature DB >> 16425095

Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).

Maria Hedelin1, Asa Klint, Ellen T Chang, Rino Bellocco, Jan-Erik Johansson, Swen-Olof Andersson, Satu-Maarit Heinonen, Herman Adlercreutz, Hans-Olov Adami, Henrik Grönberg, Katarina Augustsson Bälter.   

Abstract

OBJECTIVE: Based on evidence that phytoestrogens may protect against prostate cancer, we evaluated the associations between serum enterolactone concentration or dietary phytoestrogen intake and risk of prostate cancer.
METHODS: In our Swedish population-based case-control study, questionnaire-data were available for 1,499 prostate cancer cases and 1,130 controls, with serum enterolactone levels in a sub-group of 209 cases and 214 controls. Unconditional logistic regression was performed to estimate multivariate odds ratios (ORs) and 95% confidence intervals (CIs) for associations with risk of prostate cancer.
RESULTS: High intake of food items rich in phytoestrogens was associated with a decreased risk of prostate cancer. The OR comparing the highest to the lowest quartile of intake was 0.74 (95% CI: 0.57-0.95; p-value for trend: 0.01). In contrast, we found no association between dietary intake of total or individual lignans or isoflavonoids and risk of prostate cancer. Intermediate serum levels of enterolactone were associated with a decreased risk of prostate cancer. The ORs comparing increasing quartiles of serum enterolactone concentration to the lowest quartile were, respectively, 0.28 (95% CI: 0.15-0.55), 0.63 (95% CI: 0.35-1.14) and 0.74 (95% CI: 0.41-1.32).
CONCLUSIONS: Our results support the hypothesis that certain foods high in phytoestrogens are associated with a lower risk of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425095     DOI: 10.1007/s10552-005-0342-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  35 in total

1.  Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells.

Authors:  Li-Hua Chen; Jing Fang; Zhijian Sun; Huaixing Li; Ying Wu; Wendy Demark-Wahnefried; Xu Lin
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

2.  Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey.

Authors:  Michael K Reger; Terrell W Zollinger; Ziyue Liu; Josette Jones; Jianjun Zhang
Journal:  Eur J Nutr       Date:  2015-05-06       Impact factor: 5.614

Review 3.  Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.

Authors:  Aniket V Mali; Subhash B Padhye; Shrikant Anant; Mahabaleshwar V Hegde; Shivajirao S Kadam
Journal:  Eur J Pharmacol       Date:  2019-02-14       Impact factor: 4.432

4.  Phytoestrogens regulate mRNA and protein levels of guanine nucleotide-binding protein, beta-1 subunit (GNB1) in MCF-7 cells.

Authors:  Srivatcha Naragoni; Shireesha Sankella; Kinesha Harris; Wesley G Gray
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

5.  Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.

Authors:  Kathryn M Wilson; Katarina Bälter; Hans-Olov Adami; Henrik Grönberg; Anna C Vikström; Birgit Paulsson; Margareta Törnqvist; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population.

Authors:  Maria Hedelin; Marie Löf; Marita Olsson; Tommy Lewander; Björn Nilsson; Christina M Hultman; Elisabete Weiderpass
Journal:  BMC Psychiatry       Date:  2010-05-26       Impact factor: 3.630

7.  Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum.

Authors:  Niina M Saarinen; Annika I Smeds; José L Peñalvo; Tarja Nurmi; Herman Adlercreutz; Sari Mäkelä
Journal:  J Nutr Metab       Date:  2010-05-05

8.  Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.

Authors:  S-Y Park; L R Wilkens; A A Franke; L Le Marchand; K K Kakazu; M T Goodman; S P Murphy; B E Henderson; L N Kolonel
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

9.  Molecular and biochemical effects of a kola nut extract on androgen receptor-mediated pathways.

Authors:  Rajasree Solipuram; Sowmya Koppula; Angela Hurst; Kinesha Harris; Srivatcha Naragoni; Krystal Fontenot; Wesley Gray
Journal:  J Toxicol       Date:  2008-10-13

10.  Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats.

Authors:  Jessica R Tolman; Edwin D Lephart; Kenneth Dr Setchell; Dennis L Eggett; Merrill J Christensen
Journal:  Nutr Metab (Lond)       Date:  2008-11-10       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.